These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 29322839

  • 1. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
    Zhang JJ, Cao XC, Zheng XY, Wang HY, Li YW.
    J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
    [Abstract] [Full Text] [Related]

  • 2. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
    Cattani P, Zannoni GF, Ricci C, D'Onghia S, Trivellizzi IN, Di Franco A, Vellone VG, Durante M, Fadda G, Scambia G, Capelli G, De Vincenzo R.
    J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
    [Abstract] [Full Text] [Related]

  • 3. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 4. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
    Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M, the New Technology for Cervical Cancer 2 Working Group.
    J Natl Cancer Inst; 2021 Mar 01; 113(3):292-300. PubMed ID: 32745170
    [Abstract] [Full Text] [Related]

  • 5. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L, Husaiyin S, Zhao F, Rezhake R, Niyazi M.
    Clin Lab; 2018 Sep 01; 64(9):1363-1371. PubMed ID: 30274003
    [Abstract] [Full Text] [Related]

  • 6. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S.
    Oncol Rep; 2012 Jul 01; 28(1):346-52. PubMed ID: 22484610
    [Abstract] [Full Text] [Related]

  • 7. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R, Hu SY, Zhao S, Xu XQ, Zhao XL, Zhang L, Wang Y, Zhang X, Pan QJ, Qiao YL, Zhao FH.
    Int J Cancer; 2019 Jan 01; 144(1):34-42. PubMed ID: 29943809
    [Abstract] [Full Text] [Related]

  • 8. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
    Wang HY, Park S, Kim S, Lee D, Kim G, Kim Y, Park KH, Lee H.
    Am J Clin Pathol; 2015 Mar 01; 143(3):344-51. PubMed ID: 25696792
    [Abstract] [Full Text] [Related]

  • 9. Performance of an HPV 16/18 E6 oncoprotein test for detection of cervical precancer and cancer.
    Ferrera A, Valladares W, Cabrera Y, de la Luz Hernandez M, Darragh T, Baena A, Almonte M, Herrero R.
    Int J Cancer; 2019 Oct 15; 145(8):2042-2050. PubMed ID: 30684396
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S, Iñarrea Fernández A, Lamas González MJ, Sarán Diez MT, Cid Lama A, Alvarez Martín MJ, Pato Mosquera M, López-Miragaya I, Estévez N, Torres Piñón J, Oña Navarro M.
    J Med Virol; 2013 Jun 15; 85(6):1063-8. PubMed ID: 23588733
    [Abstract] [Full Text] [Related]

  • 11. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D, Bartosińska-Dyc A, Migdalska-Sęk M, Czarnecka KH, Nawrot E, Domańska D, Szyłło K, Brzeziańska E.
    Med Oncol; 2014 Mar 15; 31(3):842. PubMed ID: 24436016
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G.
    Mol Diagn; 2004 Mar 15; 8(1):57-64. PubMed ID: 15230643
    [Abstract] [Full Text] [Related]

  • 13. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B, Xue M.
    Genet Mol Res; 2015 Sep 08; 14(3):10473-81. PubMed ID: 26400278
    [Abstract] [Full Text] [Related]

  • 14. Distribution of human papillomavirus 16 E6/E7 variants in cervical cancer and intraepithelial neoplasia in Chinese women.
    Ding T, Wang X, Ye F, Cheng X, Lu W, Xie X.
    Int J Gynecol Cancer; 2010 Nov 08; 20(8):1391-8. PubMed ID: 21051983
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients.
    Benevolo M, Terrenato I, Mottolese M, Marandino F, Carosi M, Rollo F, Ronchetti L, Muti P, Mariani L, Sindico S, Vocaturo G, Vocaturo A.
    Cancer Causes Control; 2011 Jun 08; 22(6):869-75. PubMed ID: 21424209
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
    Wu MZ, Li WN, Cha N, Tian LX, Zhang YI, Wu X, Guo KJ, Wu GP.
    Cell Transplant; 2018 Sep 08; 27(9):1401-1406. PubMed ID: 30056761
    [Abstract] [Full Text] [Related]

  • 17. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
    Coquillard G, Palao B, Patterson BK.
    Gynecol Oncol; 2011 Jan 08; 120(1):89-93. PubMed ID: 20950847
    [Abstract] [Full Text] [Related]

  • 18. Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women.
    Zhao J, Zhu J, Guo J, Zhu T, Zhong J, Liu M, Ruan Y, Liao S, Li F.
    J Med Virol; 2020 Mar 08; 92(3):372-381. PubMed ID: 31670402
    [Abstract] [Full Text] [Related]

  • 19. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
    Fan Y, Shen Z.
    Pathol Res Pract; 2018 May 08; 214(5):767-775. PubMed ID: 29655523
    [Abstract] [Full Text] [Related]

  • 20. Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.
    Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, Logan C, Furuberg L, O'Leary J, Martin C.
    J Virol Methods; 2009 Jan 08; 155(1):61-6. PubMed ID: 18955086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.